Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
Ma X, Yang S, Zhang T, Wang S, Yang Q, Xiao Y, Shi X, Xue P, Kang Y, Liu G, Sun ZJ, Xu Z.
Ma X, et al. Among authors: liu g.
Acta Pharm Sin B. 2022 Jan;12(1):451-466. doi: 10.1016/j.apsb.2021.05.016. Epub 2021 May 21.
Acta Pharm Sin B. 2022.
PMID: 35127398
Free PMC article.